Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma

被引：65

作者：

Booken, N. ^{[1
]}

Heck, M. ^{[1
]}

Nicolay, J. P. ^{[1
]}

Klemke, C. D. ^{[1
]}

Goerdt, S. ^{[1
]}

Utikal, J. ^{[1
]}

机构：

[1] Univ Heidelberg, Dept Dermatol Venereol & Allergol, Univ Med Ctr Mannheim, D-68135 Mannheim, Germany

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2011年 / 164卷 / 03期

关键词：

RECEPTOR ANTAGONIST APREPITANT; EFFICACY;

D O I：

10.1111/j.1365-2133.2010.10108.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：665 / 667

页数：3

共 12 条

[1] Neuropeptides and their receptors in psoriatic skin in relation to pruritus
Chang, S-E.
Han, S-S.
Jung, H-J.
Choi, J-H.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (06) : 1272 - 1277
[2] The use of amitriptyline in mycosis fungoides
Coe, P
[J]. PALLIATIVE MEDICINE, 1999, 13 (03) : 264 - 264
[3] Significant impact of cutaneous T-cell lymphoma on patients' quality of life - Results of a 2005 National Cutaneous Lymphoma Foundation Survey
Demierre, Marie-France
Gan, Stephanie
Jones, Judy
Miller, Donald R.
[J]. CANCER, 2006, 107 (10) : 2504 - 2511
[4] Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma
Demierre, Marie-France
Taverna, Josephine
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) : 543 - 544
[5] Aprepitant as an Antipruritic Agent?.
Duval, Arnaud
Dubertret, Louis
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (14) : 1415 - 1416
[6] Lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder
Keller, M
Montgomery, S
Ball, W
Morrison, M
Snavely, D
Liu, GH
Hargreaves, R
Hietala, J
Lines, C
Beebe, K
Reines, S
[J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (03) : 216 - 223
[7] Metze D, 1999, J AM ACAD DERMATOL, V41, P533, DOI 10.1016/S0190-9622(99)70292-6
[8] Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting - Results from a randomized, double-blind, placebo-controlled trial in Latin America
Poli-Bigelli, S
Rodrigues-Pereira, J
Carides, AD
Ma, GGJ
Eldridge, K
Hipple, A
Evans, JK
Horgan, KJ
Lawson, F
[J]. CANCER, 2003, 97 (12) : 3090 - 3098
[9] Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
Staender, Sonja
Siepmann, Dorothee
Herrgott, Ilka
Sunderkoetter, Cord
Luger, Thomas A.
[J]. PLOS ONE, 2010, 5 (06):
[10] Aprepitant against pruritus in patients with solid tumours
Vincenzi, Bruno
Fratto, Maria Elisabetta
Santini, Daniele
Tonini, Giuseppe
[J]. SUPPORTIVE CARE IN CANCER, 2010, 18 (09) : 1229 - 1230

← 1 2 →